Dergiler / Turkish journal of nephrology (Online) / 2022 / Cilt: 31 - Sayı: 1

The Impact of COVID-19 on Patients with Chronic Kidney Disease and Predictive Factors for Disease Mortality

Sayfa
49–57
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Interventions for optimal oxygenation, early attenuation of the inflammatory response, and prevention of acute kidney injury may improve the prognosis of chronic kidney disease patients with COVID-19.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: We aimed to describe clinical characteristics and course of chronic kidney disease patients with COVID-19 and to identify determinants of in-hospital mortality.
📊
Temel Bulgular & Veri:Methods: Seventy-one chronic kidney disease patients with COVID-19 were enrolled.
💡
Sonuç & Katkı:Interventions for optimal oxygenation, early attenuation of the inflammatory response, and prevention of acute kidney injury may improve the prognosis of chronic kidney disease patients with COVID-19.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: We aimed to describe clinical characteristics and course of chronic kidney disease patients with COVID-19 and to identify determinants of in-hospital mortality. Methods: Seventy-one chronic kidney disease patients with COVID-19 were enrolled. The primary endpoint was death from all causes discussed in this article. The relationship between mortality and demographic, clinical, and laboratory data were examined. Results: Of 71 patients, 29 (40.8%) died. Dead were older, were more likely to have low critical oxygen saturation (SpO2) and deterioration of renal function, and exhibited less favorable laboratory features, including higher neutrophils, neutrophil to lymphocyte ratio, and systemic immune-inflammation index, as well as a lower lymphocyte. Acute kidney injury rate was high (71.8%) and 23.5% needed dialysis. Disease outcome did not differ across baseline chronic kidney disease stages. Systemic immune-inflammation index had a higher prediction accuracy for in-hospital mortality (AUC = 0.732). Patients in the high systemic immune-inflammation index group were older, had higher peak Cr, higher rate of acute kidney injury (85.3% vs. 59.5%), severe disease (79.4% vs. 35.1%), and mortality (64.7% vs. 18.9%) compared to those in low systemic immune-inflammation index group. Older age (>72 years), SpO2 ≤90%, high systemic immune-inflammation index, and severe acute kidney injury requiring dialysis were predictors of in-hospital mortality. Conclusion: Chronic kidney disease patients with COVID-19 had a high mortality rate associated with older age, acute kidney injury requiring dialysis, higher systemic immune-inflammation index, and lower SpO2. Systemic immune-inflammation index at admission may be used for early identification of those at risk. Interventions for optimal oxygenation, early attenuation of the inflammatory response, and prevention of acute kidney injury may improve the prognosis of chronic kidney disease patients with COVID-19.

🔖

Bu Makaleye Atıf Yap

ÖZDEMİR, A., KOÇAK, S. Y., YILMAZ, M., AYDIN, Ö. A. (2022). The Impact of COVID-19 on Patients with Chronic Kidney Disease and Predictive Factors for Disease Mortality. Turkish journal of nephrology (Online), Cilt: 31 - Sayı: 1, 49–57. https://ajindex.com/articles/612817

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Wang X, Fang X, Cai Z, et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and metaanalysis. Research. 2020
  2. 2402961. [CrossRef] 2. Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019
  3. 23(4):437-447. [CrossRef] 3. Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-2019) infection. Int Urol Nephrol. 2020
  4. 52(6):1193-1194. [CrossRef] 4. Ateya AM. CKD patients: a high-risk category for severe COVID-19. J Med Virol. 2021
  5. 93(7):4086-4087. [CrossRef] 5. Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020
  6. 584(7821):430-436. [CrossRef] 6. Li H, Huang J-b, Pan W, Zhang CT, Chang XY,Yang B. Systemic Immune-inflammatory Index predicts prognosis of patients with COVID-19: a retrospective study. researchsquare.com. 2020. [CrossRef] 7. Pan F, Ye T, Sun P, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. 2020
  7. 295(3):715-721. [CrossRef] 8. Kellum JA, Lameire N, Aspelin P, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012
  8. Gok M, Cetinkaya H, Kandemir T, et al. Chronic kidney disease predicts poor outcomes of COVID-19 patients. Int Urol Nephrol. 2021
  9. 53(9):1891-1898. [CrossRef] 10. Dirim AB, Demir E, Yadigar S, et al. COVID-19 in chronic kidney disease: a retrospective, propensity score-matched cohort study. Int Urol Nephrol. 2020
  10. 53(10):2117-2125. [CrossRef] 11. Trabulus S, Karaca C, Balkan II, et al. Kidney function on admission predicts in-hospital mortality in COVID-19. PLoS One. 2020
  11. 15(9):e0238680. [CrossRef] 12. Ozturk S, Turgutalp K, Arici M, et al. Characteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID-19: a multicenter nationwide controlled study. Int J Clin Pract. 2021
  12. 75(9):e14428. [CrossRef] 13. Coca A, Burballa C, Centellas-Pérez FJ, et al. Outcomes of COVID-19 among hospitalized patients with non-dialysis CKD. Front Med. 2020
  13. 615312. [CrossRef] 14. Xie J, Covassin N, Fan Z, et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin Proc. 2020
  14. 95(6):1138- 1147. [CrossRef]